Plain-English translation of NCT06455332 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is looking at whether changes in the optic nerve—the nerve that connects your eye to your brain—can help predict if someone with early multiple sclerosis symptoms will go on to develop clinically definite multiple sclerosis. Researchers will follow people with a recent first episode of neurological symptoms (called a clinically isolated syndrome) and use specialized eye and brain imaging to track whether optic nerve involvement helps predict who will have a second relapse and when that might happen.
Right now, doctors use specific criteria to diagnose multiple sclerosis, but the optic nerve is not officially part of those criteria—even though eye nerve problems are very common in people with MS. This study exists to find out whether paying attention to the optic nerve early on could help doctors better predict disease progression and identify which patients need treatment sooner.
You likely qualify if…
You likely don't qualify if…
You will be part of a follow-up study where researchers monitor your condition over time using specialized imaging tests focused on your optic nerve and brain. You will not receive any experimental medication—instead, your doctors will treat you according to standard medical recommendations while the research team tracks whether optic nerve changes help predict when or if you develop a second relapse of symptoms.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France